Cargando…

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer

INTRODUCTION: Whole-gland salvage treatment of radiorecurrent prostate cancer has a high rate of severe toxicity. The standard of care in case of a biochemical recurrence is androgen deprivation treatment, which is associated with morbidity and negative effects on quality of life. A salvage treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maenhout, Metha, Peters, Max, van Vulpen, Marco, Moerland, Marinus A., Meijer, Richard P., van den Bosch, Maurice A. A. J., Nguyen, Paul L., Frank, Steven J., van der Voort van Zyp, Jochem R. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762090/ https://www.ncbi.nlm.nih.gov/pubmed/29333958 http://dx.doi.org/10.1177/1533034617741797

Ejemplares similares

Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives
por: van Son, Marieke, et al.
Publicado: (2018)

Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients
por: van Son, Marieke, et al.
Publicado: (2020)

Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study
por: Willigenburg, Thomas, et al.
Publicado: (2020)

Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Willigenburg, Thomas, et al.
Publicado: (2021)

Health-related quality of life after ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: reporting the patient’s perspective
por: van Son, Marieke, et al.
Publicado: (2020)

Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy
por: Peters, Max, et al.
Publicado: (2016)

Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
por: Van Son, Marieke J, et al.
Publicado: (2018)

Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review
por: Duijzentkunst, D. A. Smit, et al.
Publicado: (2016)

Perineal recurrence of prostate cancer six years after trans-perineal brachytherapy
por: Eppinga, Wietse, et al.
Publicado: (2014)

A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer
por: Khoo, Christopher C., et al.
Publicado: (2020)

Prostate Cancer – Local Treatment after Radiorecurrence: Salvage Cryoablation
por: da Silva, Rodrigo Donalisio, et al.
Publicado: (2018)

Salvage Transoral Laser Microsurgery for Radiorecurrent Laryngeal Cancer: Indications, Limits, and Outcomes
por: Meulemans, J., et al.
Publicado: (2017)

PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure
por: Shah, T T, et al.
Publicado: (2016)

Oncologic outcome of salvage high-intensity focused ultrasound (HIFU) in radiorecurrent prostate cancer. A systematic review
por: Maestroni, Umberto, et al.
Publicado: (2021)

Value of Targeted Biopsies and Combined PSMA PET/CT and mp-MRI Imaging in Locally Recurrent Prostate Cancer after Primary Radiotherapy
por: Rasing, Marnix, et al.
Publicado: (2022)

Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator
por: Willigenburg, Thomas, et al.
Publicado: (2021)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results
por: Anttinen, Mikael, et al.
Publicado: (2020)

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Patient preferences for treatment modalities for localised prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Clinical implementation of MRI-based organs-at-risk auto-segmentation with convolutional networks for prostate radiotherapy
por: Savenije, Mark H. F., et al.
Publicado: (2020)

Prostate Cancer – Local Treatment after Radiorecurrence: Surgery - Back to the future?
por: Reis, Leonardo O., et al.
Publicado: (2018)

Salvage focal brachytherapy in castration‐resistant prostate cancer with neuroendocrine differentiation after radiation therapy
por: Komori, Takahiro, et al.
Publicado: (2022)

Multi-Parametric MRI-Directed Focal Salvage Permanent Interstitial Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate: A Novel Approach
por: Wallace, T., et al.
Publicado: (2013)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
por: Lacy, John M., et al.
Publicado: (2016)

Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Yoshida, Soichiro, et al.
Publicado: (2021)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2016)

Prostate Cancer – Local Treatment after Radiorecurrence: HIFU – High-Intensity Focused Ultrasound
por: Zequi, Stênio de Cássio, et al.
Publicado: (2018)

Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity
por: Opbroek, Thirza, et al.
Publicado: (2023)

Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020)

Editorial Comment to Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Hirayama, Yukiyoshi, et al.
Publicado: (2021)

Natural History of Untreated Prostate Specific Antigen Radiorecurrent Prostate Cancer in Men with Favorable Prognostic Indicators
por: Martin, Neil E., et al.
Publicado: (2014)

MRI‐based synthetic CT shows equivalence to conventional CT for the morphological assessment of the hip joint
por: Florkow, Mateusz C., et al.
Publicado: (2021)

Problems and Promises of Introducing the Magnetic Resonance Imaging Linear Accelerator Into Routine Care: The Case of Prostate Cancer
por: Hehakaya, Charisma, et al.
Publicado: (2020)

Fast and accurate deformable contour propagation for intra-fraction adaptive magnetic resonance-guided prostate radiotherapy
por: Willigenburg, Thomas, et al.
Publicado: (2022)

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy
por: Maspero, Matteo, et al.
Publicado: (2018)

Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations
por: Krijgsman, Oscar, et al.
Publicado: (2014)

Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review
por: Bockel, Sophie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c55bspj2fdjpnmb6govicfqvk0